Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof
View Patent ↗The present invention relates to a first group of novel viral and human associated oligonucleotides, here identified as “Genomic Address Messenger” or “GAM” oligonucleotide, and a second group of novel operon-like viral and human polynucleotides, here identified as “Genomic Record” or “GR” polynucleotide. GAM oligonucleotides selectively inhibit translation of known “target” genes, many of which are known to be involved in various viral diseases. Nucleic acid molecules are provided respectively encoding 1,655 viral and 105,537 human GAM precursor oligonucleotides, and 190 viral and 14,813 human GR polynucleotides, as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM oligonucleotides and GR polynucleotides and specific functions and utilities thereof, for detecting expression of GAM oligonucleotides and GR polynucleotides, and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.
1. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 4204050;
(b) a DNA encoding the nucleic acid of (a), wherein the DNA is identical in length to (a); or
(c) the complement of (a) or (b), wherein the complement is identical in length to the nucleic acid of (a) or (b).
2. A vector comprising an isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 4204050;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a); or
(c) a complement of (a) or (b), wherein the complement is identical in length to the nucleic acid of (a) or (b).
3. A probe comprising a heterologous sequence, wherein the heterologous sequence is selected from the group consisting of
(a) SEQ ID NO: 4204050;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a); and
(c) a complement of (a) or (b), wherein the complement is identical in length to the nucleic acid of (a) or (b).
4. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of :
(a) SEQ ID NO: 117937;
(b) a DNA encoding the nucleic acid of (a), wherein the DNA is identical in length to (a);
(c) a sequence at least 80% identical to (a) or (b), wherein the nucleic acid is 19-24 nucleotides in length; or
(d) the complement of (a)-(c), wherein the complement is identical in length to the nucleic acid of (a)-(c).
5. A vector comprising an isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO: 117937;
(b) a DNA encoding (a), wherein the DNA is identical in length to (a); or
(c) a complement of (a) or (b), wherein the complement is identical in length to the nucleic acid of (a) or (b).
6. A probe comprising a heterologous sequence, wherein the heterologous sequence is selected from the group consisting of
(a) SEQ ID NO: 117937;
(b) a DNA encoding the nucleic acid of (a), wherein the DNA is identical in length to (a);
(c) a sequence at least 80% identical to (a) or (b), wherein the nucleic acid is 19-24 nucleotides in length; and
(d) the complement of (a)-(c), wherein the complement is identical in length to the nucleic acid of (a)-(c).